InsidersTradesSigma
Track the ダイト株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ダイト株式会社 has logged 14 public disclosures. Market capitalisation: €36bn. The latest transaction was reported on 4 February 2026 (Holding update). Among the most active insiders: Kaname Capital, L.P.. Every trade is free.
14
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ダイト株式会社 Hold (neutral), based on 1 analysts. Average price target: JP¥1,400.
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,009 of 28,548 companies
50.6
score / 100
Value59
Quality42
FCF yld-3.1%
Earn yld5.3%
EV/EBITDA6.5x
ROE6.0%
Gross mgn17%
Net mgn3.8%
Debt/EBITDA1.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 February 2026
Declarations14 total
ShareXTKSEDINET:S100XIZW
ShareXTKSEDINET:S100WJ75
ShareXTKSEDINET:S100WI7S
ShareXTKSEDINET:S100VWCS
ShareXTKSEDINET:S100TTI6
ShareXTKSEDINET:S100TD06
ShareXTKSEDINET:S100TAFQ
ShareXTKSEDINET:S100T457
ShareXTKSEDINET:S100SP60
100.0% of flowShareXTKSEDINET:S100RDP2
ShareXTKSEDINET:S100QVLG
14 of 14 declarations
Acerca de ダイト株式会社
Daito Co., Ltd. es una empresa del sector de la salud y farmacéutico, cotizada en el mercado XTKS. Se especializa en el desarrollo y comercialización de productos farmacéuticos y sanitarios.